Zura Bio Limited/$ZURA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Ticker
$ZURA
Sector
Primary listing
Employees
30
Headquarters
Website
Zura Bio Limited Metrics
BasicAdvanced
$131M
-
-$0.72
-0.06
-
Price and volume
Market cap
$131M
Beta
-0.06
52-week high
$2.18
52-week low
$0.97
Average daily volume
740K
Financial strength
Current ratio
8.397
Quick ratio
8.263
Profitability
EBITDA (TTM)
-72.339
Management effectiveness
Return on assets (TTM)
-26.05%
Return on equity (TTM)
-43.55%
Valuation
Price to book
0.99
Price to tangible book (TTM)
0.99
Price to free cash flow (TTM)
-4.206
Free cash flow yield (TTM)
-23.78%
Free cash flow per share (TTM)
-0.478
Growth
Earnings per share change (TTM)
38.35%
Zura Bio Limited News
AllArticlesVideos
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference
Business Wire·5 days ago
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
Business Wire·2 weeks ago
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zura Bio Limited stock?
Zura Bio Limited (ZURA) has a market cap of $131M as of August 25, 2025.
What is the P/E ratio for Zura Bio Limited stock?
The price to earnings (P/E) ratio for Zura Bio Limited (ZURA) stock is 0 as of August 25, 2025.
Does Zura Bio Limited stock pay dividends?
No, Zura Bio Limited (ZURA) stock does not pay dividends to its shareholders as of August 25, 2025.
When is the next Zura Bio Limited dividend payment date?
Zura Bio Limited (ZURA) stock does not pay dividends to its shareholders.
What is the beta indicator for Zura Bio Limited?
Zura Bio Limited (ZURA) has a beta rating of -0.06. This means that it has an inverse relation to market volatility.